Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1983 Jul;53(1):109–114.

Further evidence for T cell abnormalities in chronic lymphocytic leukaemia of the B cell type.

F Herrmann, G Sieber, Z Chen, B Enders, B Komischke, H Rühl
PMCID: PMC1535548  PMID: 6347474

Abstract

Functional properties were studied in the purified T cell fraction of patients with chronic lymphocytic leukaemia of the B cell type (B-CLL). This analysis included the evaluation of T suppressor activity when investigated patients' T cells were co-cultured together with allogenic normal B and OKT4 enriched T cells in the presence of pokeweed mitogen (PWM). The Ig secreting cells (ISC) were assessed in a reverse haemolytic plaque assay (RHPA). Antibody-dependent cytotoxicity (ADCC) and natural killer activity (NK) were determined in a 51Cr release assay. Furthermore, purified T cells reactive with the monoclonal antibody HNK1, known to recognize most effector cells in ADCC and NK, were enumerated using an indirect immunofluorescence. Our results revealed increased T suppressor cell activity and markedly deficient NK activity in peripheral blood lymphocytes (PBL), T cell and T gamma cell fractions from B-CLL patients, whereas ADCC potential was only increased in T cells and T gamma cells. Accordingly, T cells were recognized by HNK1 in greater numbers in B-CLL patients than in healthy subjects. Our data suggest that there may be a link between our findings and the hypogammaglobulinaemia as well as the increased incidence of second neoplasias reported in CLL.

Full text

PDF
109

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abo T., Balch C. M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol. 1981 Sep;127(3):1024–1029. [PubMed] [Google Scholar]
  2. Catovsky D., Lauria F., Matutes E., Foa R., Mantovani V., Tura S., Galton D. A. Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia. Br J Haematol. 1981 Apr;47(4):539–544. doi: 10.1111/j.1365-2141.1981.tb02682.x. [DOI] [PubMed] [Google Scholar]
  3. Faguet G. B. Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes. J Clin Invest. 1979 Jan;63(1):67–74. doi: 10.1172/JCI109280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Falkoff R. M., Peters M., Fauci A. S. T cell enrichment and depletion of human peripheral blood mononuclear cell preparations. Unexpected findings in the study of the functional activities of the separated populations. J Immunol Methods. 1982;50(1):39–49. doi: 10.1016/0022-1759(82)90302-7. [DOI] [PubMed] [Google Scholar]
  5. Fernandez L. A., MacSween J. M., Langley G. R. T cell function in untreated B cell chronic lymphocytic leukemia. Cancer. 1977 Mar;39(3):1168–1174. doi: 10.1002/1097-0142(197703)39:3<1168::aid-cncr2820390323>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  6. Gupta S., Fernandes G., Nair M., Good R. A. Spontaneous and antibody-dependent cell-mediated cytotoxicity by human T cell subpopulations. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5137–5141. doi: 10.1073/pnas.75.10.5137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Han T., Dadey B. In vitro functional studies of mononuclear cells in patients with CLL: evidence for functionally normal T lymphocytes and monocytes and abnormal B lymphocytes. Cancer. 1979 Jan;43(1):109–117. doi: 10.1002/1097-0142(197901)43:1<109::aid-cncr2820430117>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  8. Herrmann F., Lochner A., Philippen H., Jauer B., Rühl H. Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell type. Clin Exp Immunol. 1982 Jul;49(1):157–162. [PMC free article] [PubMed] [Google Scholar]
  9. Hersey P., Wotherspoon J., Reid G., Gunz F. W. Hypogammaglobulinaemia associated with abnormalities of both B and T lymphocytes in patients with chronic lymphatic leukaemia. Clin Exp Immunol. 1980 Mar;39(3):698–707. [PMC free article] [PubMed] [Google Scholar]
  10. Hokland P., Ellegaard J. Immunological studies in chronic lymphocytic leukemia.-II. Natural killer- and antibody-dependent cellular cytotoxicity potentials of malignant and non-malignant lymphocyte subsets and the effect of alpha-interferon. Leuk Res. 1981;5(4-5):349–355. doi: 10.1016/0145-2126(81)90007-2. [DOI] [PubMed] [Google Scholar]
  11. Kay N. E., Johnson J. D., Stanek R., Douglas S. D. T-cell subpopulations in chronic lymphocytic leukemia: abnormalities in distribtuion and in in vitro receptor maturation. Blood. 1979 Aug;54(2):540–544. [PubMed] [Google Scholar]
  12. Lauria F., Foa R., Catovsky D. Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. Scand J Haematol. 1980 Feb;24(2):187–190. doi: 10.1111/j.1600-0609.1980.tb02366.x. [DOI] [PubMed] [Google Scholar]
  13. Manusow D., Weinerman B. H. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA. 1975 Apr 21;232(3):267–269. [PubMed] [Google Scholar]
  14. Moretta L., Webb S. R., Grossi C. E., Lydyard P. M., Cooper M. D. Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med. 1977 Jul 1;146(1):184–200. doi: 10.1084/jem.146.1.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Preud'homme J. L., Seligmann M. Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. Blood. 1972 Dec;40(6):777–794. [PubMed] [Google Scholar]
  16. Rai K. R., Sawitsky A., Cronkite E. P., Chanana A. D., Levy R. N., Pasternack B. S. Clinical staging of chronic lymphocytic leukemia. Blood. 1975 Aug;46(2):219–234. [PubMed] [Google Scholar]
  17. Reinherz E. L., Kung P. C., Goldstein G., Levey R. H., Schlossman S. F. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1588–1592. doi: 10.1073/pnas.77.3.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Reinherz E. L., Kung P. C., Goldstein G., Schlossman S. F. Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol. 1979 Dec;123(6):2894–2896. [PubMed] [Google Scholar]
  19. Salmon S. E., Seligmann M. B-cell neoplasia in man. Lancet. 1974 Nov 23;2(7891):1230–1233. doi: 10.1016/s0140-6736(74)90748-x. [DOI] [PubMed] [Google Scholar]
  20. Semenzato G., Pezzutto A., Agostini C., Albertin M., Gasparotto G. T-lymphocyte subpopulations in chronic lymphocytic leukemia: a quantitative and functional study. Cancer. 1981 Nov 15;48(10):2191–2197. doi: 10.1002/1097-0142(19811115)48:10<2191::aid-cncr2820481013>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  21. Thomas Y., Sosman J., Irigoyen O., Friedman S. M., Kung P. C., Goldstein G., Chess L. Functional analysis of human T cell subsets defined by monoclonal antibodies. I. Collaborative T-T interactions in the immunoregulation of B cell differentiation. J Immunol. 1980 Dec;125(6):2402–2408. [PubMed] [Google Scholar]
  22. West W. H., Cannon G. B., Kay H. D., Bonnard G. D., Herberman R. B. Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells. J Immunol. 1977 Jan;118(1):355–361. [PubMed] [Google Scholar]
  23. Whiteside T. L., Winkelstein A., Rabin B. S. Immunologic characterization of chronic lymphocytic leukemia cells. Cancer. 1977 Mar;39(3):1109–1118. doi: 10.1002/1097-0142(197703)39:3<1109::aid-cncr2820390316>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  24. Wybran J., Chantler S., Fudenberg H. H. Isolation of normal T cells in chronic lymphatic leukaemia. Lancet. 1973 Jan 20;1(7795):126–129. doi: 10.1016/s0140-6736(73)90196-7. [DOI] [PubMed] [Google Scholar]
  25. Ziegler H. W., Kay N. E., Zarling J. M. Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia. Int J Cancer. 1981 Mar 15;27(3):321–327. doi: 10.1002/ijc.2910270310. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES